TGF-β is not the principal immunosuppressive component in coagulation factor concentrates

This publication has 16 references indexed in Scilit:

• The effect of monoclonal or ion‐exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparison
  British Journal of Haematology, 1998
• Evidence for the aetiological role of blood‐borne virus infections in causing reduced lectin‐induced T‐cell proliferation in haemophilic boys
  British Journal of Haematology, 1995
• Modulation of the Immune Response by Transforming Growth Factor Beta
  International Archives of Allergy and Immunology, 1992
• The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate [see comments]
  Blood, 1991
• Assays for transforming growth factor β
  Journal of Immunological Methods, 1991
• Physicochemical Activation of Recombinant Latent Transforming Growth Factor-beta's 1, 2, and 3
  Growth Factors, 1990
• A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia
  New England Journal of Medicine, 1989
• Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions
  Biochemical and Biophysical Research Communications, 1985
• A Diffusable Factor in Scottish Coagulation Factor Concentrates Can Inhibit Lymphocyte Transformation in vitro
  Published by Wiley ,1985
• Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?
  BMJ, 1983